Trials / Sponsors / Entera Bio Ltd.
Entera Bio Ltd.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous For Hypoparathyroidism, Osteoporosis, Fractures, Bone | Phase 1 | 2023-05-11 |
| Completed | A Six-month Phase 2 Study of Oral hPTH(1-34) (EBP05) in Postmenopausal Women With Low Bone Mass Osteoporosis | Phase 2 | 2019-06-30 |
| Completed | Oral PTH(1-34) PK and PD Study in Patients With Hypoparathyroidism Hypoparathyroidism | Phase 2 | 2018-06-17 |
| Completed | A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of Hypoparathyroidism Hypoparathyroidism | Phase 2 | 2014-07-01 |
| Completed | A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) Formulations in Healthy Drug Safety and Bioavailability | Phase 1 | 2013-10-01 |
| Completed | A Three Stage, Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) in Healthy Drug Safety | Phase 1 | 2011-07-01 |